Therapeutic application of histone deacetylase inhibitors for central nervous system disorder

jerry submitted, created time 2 months 2 weeks (www.nature.com)

Histone deacetylases (HDACs) — enzymes that affect the acetylation status of histones and other important cellular proteins — have been recognized as potentially useful therapeutic targets for a broad range of human disorders. Pharmacological manipulations using small-molecule HDAC inhibitors — which may restore transcriptional balance to neurons, modulate cytoskeletal function, affect immune responses and enhance protein degradation pathways — have been beneficial in various experimental models of brain diseases

1 comment | Blog It | Email It | Keywords: multiple sclerosis MS Rubinstein-Taybi syndrome Freidreich's ataxia Rett syndrome Huntington's Huntington's disease central nervous system CNS histones HDAC histone deacetylase